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Recent research has highlighted that facial emotion recognition deficits 
are more common in people with schizophrenia, but the reason for this 
association is not well understood. Comparing facial recognition deficits 
in unaffected individuals at higher genetic risk for schizophrenia with 





We systematically reviewed studies reporting on the relationship between 
genetic risk of schizophrenia and facial emotion recognition deficits. 
Meta-analyses were performed where sufficient data were available, 
otherwise we conducted narrative summaries. Meta-analyses were performed 




34 studies were included in this review with 23 included in meta-
analyses. Meta-analysis indicated strong evidence of a deficit in facial 
emotion recognition in first-degree relatives of people with 
schizophrenia compared with controls (SMD 0.38 95%CI 0.26 to 0.51, p = 
<0.001). Further meta-analyses demonstrated strong evidence of a deficit 
in the recognition of negative valence facial expressions (SMD 0.19 CI 
0.06 to 0.32, p = 0.004) but no evidence of deficit in the recognition of 
neutral or positive valance. 
   
Conclusions 
 
There is strong evidence of facial emotion recognition deficits in first-
degree relatives of people with schizophrenia. Our findings suggest that 
such deficits in people with schizophrenia arise prior to the onset of 
the disorder, though cannot inform whether that association is causal or 
due to confounding. Emotion recognition deficits, particularly to 
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Recent research has highlighted that facial emotion recognition deficits are more common 
in people with schizophrenia, but the reason for this association is not well understood. 
Comparing facial recognition deficits in unaffected individuals at higher genetic risk for 
schizophrenia with individuals at lower genetic risk could increase our understanding of this 
relationship. 
Methods 
We systematically reviewed studies reporting on the relationship between genetic risk of 
schizophrenia and facial emotion recognition deficits. Meta-analyses were performed where 
sufficient data were available, otherwise we conducted narrative summaries. Meta-analyses 
were performed both for generalised and specific facial emotion recognition deficits. 
Results 
34 studies were included in this review with 23 included in meta-analyses. Meta-analysis 
indicated strong evidence of a deficit in facial emotion recognition in first-degree relatives of 
people with schizophrenia compared with controls (SMD 0.38 95%CI 0.26 to 0.51, p = 
<0.001). Further meta-analyses demonstrated strong evidence of a deficit in the recognition 
of negative valence facial expressions (SMD 0.19 CI 0.06 to 0.32, p = 0.004) but no evidence 
of deficit in the recognition of neutral or positive valance.   
Conclusions 
There is strong evidence of facial emotion recognition deficits in first-degree relatives of 
people with schizophrenia. Our findings suggest that such deficits in people with 
schizophrenia arise prior to the onset of the disorder, though cannot inform whether that 
association is causal or due to confounding. Emotion recognition deficits, particularly to 
negative emotions, might be useful predictors of schizophrenia risk.  
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Schizophrenia is a psychotic disorder characterised by hallucinations, delusions, 
disorganized speech or behaviour, and impaired cognitive ability. It has a lifetime risk of 
about 1% (Schizophrenia Working Group of the Psychiatric Genomics, 2014), and carries a 
significant health, social and financial burden for the individual, people close to them, and 
the wider society (Knapp et al., 2004). Our limited understanding of the aetiology of 
schizophrenia means that therapeutic options are limited. Pharmacological interventions 
are the first line  treatment, although psychological treatments aimed at addressing a 
person’s beliefs about their symptoms and at increasing adherence to medication are also 
used (Patel et al., 2014). 
 
Recent research has highlighted that facial emotion recognition deficits are more prevalent 
in people with schizophrenia (Aleman and Kahn, 2005; mandal, 1998) compared to people 
without this disorder. These are deficits in the recognition of the emotional state of another 
person by observation of their facial expression. Facial emotion recognition deficits in 
schizophrenia are associated with an extensive pattern of activation abnormalities on fMRI, 
consistent with hypoactive emotion recognition networks (Jani and Kasparek, 2018). 
Compensatory over-activation in the medial prefrontal cortex (MPFC) during threatening 
faces processing has also been demonstrated (Dong et al., 2017).  
 
These deficits are present during the prodromal phase of the illness (Green et al., 2012), in 
people with first episode psychosis (Bosnjak Kuharic et al., 2019; Daros et al., 2014) and 
those with schizophrenia (Kohler et al., 2010; Savla et al., 2013). There is evidence to 
suggest that patients with schizophrenia have specific facial emotion recognition deficits in 
the recognition of negative emotions, particularly fear and anger, compared with neutral or 
positive emotions (Addington et al., 2006).  
 
The reason for the association between facial emotion recognition deficits and 
schizophrenia is not well understood. It is possible that facial emotion recognition deficits 
occur secondary to schizophrenia or the association could be due to confounding, whereby 
schizophrenia and facial emotion recognition deficits share genetic or environmental risk 
factors.  
 
Schizophrenia has a heritability of around 80% (Cardno et al., 1999), and a family history of 
schizophrenia is one of the strongest risk factors for this disorder. Examining whether 
individuals who are at higher genetic risk for schizophrenia, but are unaffected, have an 
increased likelihood of facial emotion recognition deficits compared with individuals at 
lower genetic risk could increase our understanding of the relationship between these 
deficits and schizophrenia. Consistent evidence of association in such studies reduces 
the likelihood of reverse causation as an explanation, though they cannot discriminate 
between genetic confounding and causality.  
 
A systematic review and meta-analysis conducted in 2012 (Lavoie et al., 2013) reported that 
first-degree relatives of people with schizophrenia have deficits in facial emotion 
recognition and suggested that this is consistent with an endophenotypic process, and that 
understanding this association further may help with early detection and treatment of the 
disorder. There have been a number of studies examining the relationship between genetic 
risk for schizophrenia and facial emotion recognition deficits published since that review, 
whilst the increasing availability of data from genome-wide association studies (GWAS) 
opens up the possibility of using individual-level genetic data, rather than family history, as a 
means for studying the association between schizophrenia genetic risk and facial emotion 
recognition deficits.  
 
We aimed to systematically review the literature reporting relationships between genetic 
risk for schizophrenia in unaffected individuals, as indexed either by family history or 
individual-level genetic data, and facial emotion recognition deficits, and to examine 









A systematic review was performed in accordance with PRISMA guidelines (Moher et al., 
2009). The full search protocol was pre-registered on PROSPERO (ID: CRD42018088114). 
Whilst this protocol was developed to also identify studies examining cognitive biases 
associated with psychosis, we only present results for facial emotion recognition deficits in 
this paper.  
 
2.1 Literature search 
The following databases were searched (by DM) from inception up to October 2017: 
PsychINFO, MEDLINE, EMBASE, and MEDLINE-in-process. The search terms and strategy are 
available in our supplementary document. We restricted the search to published, peer 
reviewed studies in the English language. The reference lists of included studies were hand 
searched. Authors of conference abstracts without full text papers were contacted to 
request study data. 
 
2.2 Inclusion and exclusion criteria 
Inclusion criteria are detailed in the supplementary materials (protocol and screening 
checklist). Articles must have been published in a peer-reviewed journal and compared 
performance on a facial emotion recognition task between participants at higher genetic 
risk for schizophrenia with those at lower genetic risk. Studies that examined task 
performance in individuals with a diagnosis of schizophrenia were excluded.  
 
2.3 Definition of high genetic risk for schizophrenia 
High genetic risk for schizophrenia was defined as having a higher number of risk alleles for 
schizophrenia, having more copy number variants associated with schizophrenia, or having 
one or more first-degree relatives with schizophrenia. Where studies included first-degree 
of relatives of people with psychotic disorders more broadly, we set a threshold of at least 
70% of these having schizophrenia as an inclusion criterion.  
 
2.4 Definition of facial emotion recognition tasks 
Facial emotion recognition tasks included any test that measured a participant’s accuracy in 
identifying the emotional state of another person by the observation of their facial 
expression. This is typically achieved by showing participants photographs of a variety of 
people with different facial expressions and identifying the emotion from several response 
options.  
 
2.5 Data collection 
One author (DM) screened all abstracts and obtained full texts of papers that potentially 
met inclusion criteria. Working independently, two authors (DM and JC) screened full-text 
articles to determine if they met inclusion criteria (see ‘Screening Checklist’ in 
Supplementary Materials). Data were extracted independently (by D.M and either AP or 
DS). Any discrepancies in decisions at any stage of the screening were resolved following 
discussion with a third reviewer (SZ). 
 
2.6 Quality assessment 
The quality of individual studies was assessed by two independent reviewers (DM and either 
AP or DS) using an assessment checklist which the reviewing team designed based on the 
Newcastle-Ottawa Scale, a widely used risk of bias tool for observational studies. Total 
scores, out of maximum of four points, were calculated based on how many of the following 
criteria each study fulfilled: i) random, consecutive or complete sampling; ii) response rate 
given; iii) appropriate consideration of confounders (e.g. adjusting for variables that were 
more plausible as confounders than as mediators); iv) low genetic risk (control) group 
comparable to high risk group, based on selection method. For studies using genetic data to 
define level of risk, we assessed whether confounding by ethnicity/population stratification 
was addressed.  
 
2.7 Data analysis 
Where adequate data were provided by study authors, a meta-analysis was performed using 
the metan command in Stata 15. A random effects model was used due to the differences 
between methods in the included studies. Random effects models are more conservative 
than fixed-effects models and generate wider confidence intervals. The test score mean, 
standard deviation and sample size (n) for both the high and low risk groups were used to 
derive a standardised mean difference (SMD) and confidence intervals (CI) for each study. 
For studies that split high genetic risk participants into separate groups (e.g. siblings and 
parents), the means and standard deviations were combined according to Cochrane 
guidelines (Higgins and Green, 2008). Where insufficient data were available to conduct a 
meta-analysis, studies were summarised using a narrative synthesis. Between-study 
heterogeneity was estimated using the I2 statistic, and potential reasons for heterogeneity 
were examined using meta-regression (metareg command in Stata). We examined the 
following pre-specified variables as potential sources of variation in effect estimates: i) score 
on our quality assessment tool, ii) whether or not the facial emotion recognition test had a 
stated time limit (some tests limited the participants to answer within 5 seconds, some had 
no limit), and iii) whether the test used to assess facial emotion recognition had been 
previously validated. The likelihood of publication bias was examined using a Funnel Plot 





2927 references were identified in the search after removal of duplicates. After screening 
against title and abstract, 105 studies were assessed for full text eligibility, and 34 studies 
were included in this systematic review (see Table 1 for summary of included studies and 
Figure 1 for PRISMA flow diagram with reasons for exclusion). The included studies were 
from a range of countries, with the most common (35%) being the USA. The earliest study 
was in 1989 and the most recent 2017. Study sample sizes ranged from 24 to 4097 (median 
= 68). There were four studies in children (between 6-15 years old) and one in younger 
people aged 13-25 years old. The other 30 studies included adults across a wide age range. 
Two studies used polygenic risk scores informed by genome-wide association studies 
(GWAS) of schizophrenia to characterise genetic risk in unaffected individuals, and the 
remaining studies selected individuals based on the presence or absence of a family history 





3.1 Facial emotion recognition tests used 
The majority of studies (94%) used a facial emotion “identification” test: where the 
participants identified the emotion from a list of multiple options. The other tests used were 
facial emotion “discrimination”: discriminating between only two options; and facial 




We were able to include 23 studies that identified those at high genetic risk of schizophrenia 
based on family history in a meta-analysis of overall facial recognition score (Figure 2). This 
indicated strong evidence of a deficit in overall facial emotion recognition among people 
with a family history of schizophrenia compared with controls (SMD 0.38, 95%CI 0.26 to 
0.51, p = <0.001). There was moderate heterogeneity between the included studies with an 
I2 of 41.38% (p<0.007). However, meta-regression showed that none of the variables tested 
explained this heterogeneity (see supplementary document). There was little evidence of 
possible publication bias (see Figure 3 for funnel plot; Egger test p = 0.54).  
 
When pooling all negative emotions together (anger, disgust, fear and sadness), meta-
analysis (figure 4) shows that there was strong evidence of a deficit in those with a first-
degree relative with schizophrenia compared to controls (studies = 25, total n = 3964, SMD 
0.21 CI 0.09 to 0.33, p = 0.001; I2 = 64.6%). There was no difference for positive valence 
(happy) facial emotion recognition (figure 5, studies = 6, total n = 588, SMD -0.05, CI -0.31 to 
0.22, p = 0.734) or neutral faces (figure 6, studies = 2, total n = 163, SMD -0.01, CI -0.31 to 
0.30, p = 0.968, I2 = 0%), but these were based on fewer studies and confidence intervals 
overlapped substantially with those for negative emotions.  
 
We also performed separate meta-analyses on the eight studies that presented results for 
specific emotions (anger, disgust, fear, sadness, surprise and happiness, see supplementary 
documents for meta-analyses Forrest plots). There was some evidence that first-degree 
relatives were worse than controls at recognising anger (studies = 8, total n=1276; SMD 
0.27, 95%CI 0.13 to 0.42; p = <0.001; I2 = 19.7%) and disgust (studies = 3, total n = 308, SMD 
0.37 CI 0.07 to 0.67, p = 0.017, I2 = 26.5%). The standardised mean differences were also 
lower for first-degree relatives compared with controls, but the evidence was much weaker, 
for fear (studies = 8, total n = 1255, SMD 0.23, CI -0.05 to 0.50, p = 0.103, I2 = 72.4%) , 
surprise (studies = 3, total n = 308, SMD 0.24, CI -0.08 to 0.56, p = 0.141, I2 = 33.1%) and 
sadness (studies = 6, total n = 1125, SMD 0.09 CI -0.20 to 0.39, p = 0.55; I2 = 71.7%). 
 
3.3 Narrative summaries 
In addition to the studies presented in the results section, our review includes three studies 
of first-degree relatives vs control group that we were unable to incorporate into our meta-
analysis. These studies did not provide data that to allow inclusion in our meta-analyses. All 
three studies showed results in keeping with the results of our meta-analyses. Two provided 
strong evidence that those at high risk of schizophrenia performed less well at overall facial 
emotion recognition than those at low risk (Cohen’s d -0.31, p<0.001 (Kohler et al., 2014); 
Cohen’s d -0.39, p<0.0001 (Calkins et al., 2010). In the third study (Yang et al., 2015) 
separate emotions were tested, and we calculated p-values comparing relatives to controls 
based on the means for both high and low intensity of each emotion presented in the paper. 
The strongest evidence of a deficit in the relatives group compared to control group was p = 
0.068 for recognition of high intensity fear. We were unable to combine the results for each 
intensity of emotion to allow us to include this study in our meta-analysis because the 
proportion of faces at each intensity was not stated. 
 
3.4 Studies based on polygenic risk scores 
Two studies used polygenic risk scores to define genetic risk, the first examining multiple 
risk scores derived using different p-thresholds (pT), and the second examining a single risk 
score derived at a pT of <0.05. In a study of facial emotion recognition ability in 8-year-old 
children within the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort (n = 
4097), there was weak evidence of poorer performance on facial emotion recognition tasks 
in those with higher genetic risk when testing for sad (p=0.032), but not happy (p = 0.222), 
angry (p = 0.175), or fearful (p = 0.456) emotions (Coleman et al., 2017). In the other study, 
of 4303 participants aged 8-21 in the USA, there was no evidence that polygenic risk for 
schizophrenia was associated with facial emotion recognition accuracy (Germine et al., 
2016). 
 
3.5 Quality assessment 
The quality assessment of included studies is shown in supplementary documents, table 1. 
In summary, only two of the 34 included studies (6%) reported a participation response rate. 
Three studies (9%) reported using random, consecutive or complete sampling. Seven (21%) 
had a low genetic risk group that was deemed comparable to the high genetic risk group 
based on the sampling strategy. 6 studies (18%) adjusted for variables that we considered 
could be confounding factors of the association between genetic risk for schizophrenia and 
cognitive biases. 16 (47%) adjusted for variables that are more plausible as mediators than 





This review presents a summary of the findings from our systematic review of the research 
examining the relationship between genetic risk of schizophrenia and facial emotion 
recognition deficits. We are able to update the research of this relationship since the meta-
analysis performed by Lavoie et al in 2012 by including 17 additional studies investigating 
overall emotion recognition deficits. We also present additional meta-analyses of facial 
emotion recognition deficits for negative, positive and neutral valence, as well as specific 
facial emotions including anger, disgust, fear, sadness, surprise and happiness. Our findings 
demonstrate strong evidence of deficits in negative facial emotion recognition in those with 
first-degree relatives with schizophrenia, but no evidence of a deficit for recognition of 
neutral or positive facial emotion recognition. All three studies included as narrative 
summarises in the results section showed results in keeping with the results of our meta-
analyses. 
 
Test scores for specific emotions showed strong evidence for a deficit in recognising anger 
and disgust amongst first-degree relatives of people with schizophrenia, weaker evidence of 
deficits in recognition for fear and surprise, and no evidence of a difference for recognising 
happy or neutral faces. Our meta-analysis showed that there was strong evidence of overall 
deficits in recognising facial emotions with a negative valence in people with first-degree 
relatives with schizophrenia. Such a deficit in interpreting other people’s negative emotional 
states could potentially lead to misinterpretation of situations. However, the majority of 
studies included in our review did not present data for specific facial emotion recognition 
deficits, so we are unable to draw firm conclusions as to whether there are deficits in 
specific emotions in relatives of people with schizophrenia, or whether deficits are only for 
negative emotions give that few studies examined positive or neutral emotions. 
 
Our review also includes two studies that examined an association between polygenic risk 
scores for schizophrenia and facial emotion recognition test scores. Neither study reported 
clear evidence of an association, although one reported an association with facial emotion 
recognition speed. As there was no association with sensorimotor speed, the authors 
hypothesised that speed of facial emotion recognition might slow before deficits in 
recognition are apparent. Given the substantially larger sample sizes of the two polygenic 
risk studies (mean N = 4200) compared with the family history studies (mean N = 192), it is 
somewhat surprising that the evidence of facial emotion recognition deficits was so much 
weaker in the former, given the likely increased statistical power of these studies. It is 
possible that change in facial emotion recognition ability does not occur across the 
continuum of genetic risk, but only at the high risk end (which would be more likely to be 
captured by sampling first-degree relatives, hence offsetting the power loss due to smaller 
sample sizes). The studies that examined genetic risk scores did not test non-linear models 
to explicitly test this hypothesis. Another explanation is that genetic risk is not causally 
related to facial emotion recognition, and the association with family history of 
schizophrenia is confounded by other characteristics related to family environment, such as 
increased levels of stress or adversity in children where a parent or sibling has 
schizophrenia. 
 
Our quality assessment found that the included studies were generally of poor quality. In 
our meta-analysis, we found strong evidence of an associated between emotion recognition 
deficits in those with first-degree relatives with schizophrenia compared with those without. 
However, there was moderate heterogeneity between studies which was not explained by 
our meta-regression of study quality, test used or whether test response was time limited. 
 
An important observation in our review is that less than half of the studies (44%) included 
made an attempt to address confounding. However, most adjusted for characteristics such 
as educational attainment, IQ, other measures of cognitive function, substance use, and 
psychiatric symptoms, which are perhaps easier to envisage as potential mediators of the 
effect of family history (or genetic risk for schizophrenia) on emotion recognition, rather 
than as confounders of this relationship. If this is the case, then adjusting for these would 
lead to an underestimate of the true causal effect of genetic risk on cognitive biases in these 
studies. 
 
Our results suggest that facial emotion recognition deficits are not a consequence of 
schizophrenia given that these deficits are present in unaffected first-degree relatives. The 
effect size of these deficits was always lower in first-degree relatives than those reported in 
people with schizophrenia (Alfimova et al., 2013; Bediou et al., 2007), which might reflect a 
greater genetic risk, although could also indicate that pre-morbid deficits increase in some 
people with schizophrenia following the first episode of psychosis. More longitudinal 
research is required to determine if emotion recognition deficits increase the risk of the 
development of schizophrenia onset or relapse. However, such observational studies will 
always be limited in their ability to determine causality due to concerns around residual 
confounding. It is probably only through trials of interventions targeting emotion 
recognition deficits or causal inference methods, such as Mendelian randomisation (once 
genetic instruments for these deficits become available, that our ability to determine causal 
effects of emotion recognition on schizophrenia will be substantially improved. 
 
Computational and animal models of perception and learning (Fletcher and Frith, 2009) 
implicate dopaminergic and glutamatergic function as fundamental pathways involved in 
both perception and belief formation, whilst genes involved in these pathways have been 
identified as risk variants for schizophrenia in a recent GWAS (Schizophrenia Working Group 
of the Psychiatric Genomics, 2014). Furthermore, genetic risk for schizophrenia has been 
associated with greater risk of being exposed to childhood trauma, which itself has been 
associated with facial emotion recognition deficits (da Silva Ferreira et al., 2014). Plausible 
explanations of how higher genetic risk for schizophrenia could lead to deficits in facial 
emotion recognition, therefore exist, although given the limitations of our review, stronger 
evidence is required that this association is causal and not due to bias or confounding. 
 
4.1 Strength and limitations of review 
We were able to include a high number of studies which compared facial emotion 
recognition in those at high genetic risk of schizophrenia with those at low risk and this 
included two studies which utilised the polygenic risk score approach using data from a 
recent schizophrenia GWAS. We followed PRISMA guidelines throughout the review (see 
supplementary document). The meta-analysis was based on data from a large number of 
participants (n=3947) and the majority of studies used tests for facial emotion recognition 
that could be standardised in pooled analysis. 
 
There are also a number of important limitations with our review. Although we carried out a 
systematic and thorough search and review of the peer-reviewed, published literature, we 
may nevertheless have missed some studies that could have contributed to addressing our 
study aims, particularly given our restriction of only including English-language publications. 
We were also unable to include all studies in the meta-analyses as some studies did not 
provide the data required in the paper or on request. The lack of clear information in the 
methods section of some included studies also made precise exploration of the quality of 
studies and differences between studies difficult. This highlights the importance for authors 
to include all results in numerical form, and of a thorough documentation of study methods.  
The conclusions drawn from any review is reliant on the quality of the studies included, and 
our quality assessment shows that the included studies were generally of poor quality, 
making it difficult to draw firm conclusions about the role of schizophrenia genetic risk on 
the facial emotion recognition deficits explored. Finally, as we carried out multiple meta-
analyses, we are cautious in the interpretation of our results, particularly for the valence 








Studies using family history as a marker for genetic risk need to carefully consider the 
potential effects of confounding and distinguish this from mediation to allow appropriate 
inferences about causal effects to be made. Availability of molecular genetic data to use 
polygenic risk scoring and Mendelian randomisation (Davies et al., 2018) approaches could 
help address issues of confounding and causal direction in future studies and thereby help 





























Addington, J., Saeedi, H. & Addington, D. (2006). Facial emotion recognition: a mediator between 
cognitive and social functioning in psychosis? Schizophr Res  85, 142-50. 
Albacete, A., Bosque, C., Custal, N., Crespo, J. M., Gilabert, E., Albiach, A., Menchon, J. M. & 
Contreras, F. (2016). Emotional intelligence in non-psychotic first-degree relatives of people with 
schizophrenia. Schizophr Res  175, 103-108. 
Aleman, A. & Kahn, R. S. (2005). Strange feelings: do amygdala abnormalities dysregulate the 
emotional brain in schizophrenia? Prog Neurobiol  77, 283-98. 
Alfimova, M. V., Abramova, L. I., Barhatova, A. I., Yumatova, P. E., Lyachenko, G. L. & Golimbet, V. 
E. (2013). Facial Emotion Recognition Deficit as a Marker of Genetic Vulnerability to Schizophrenia. 
The Spanish journal of psychology  12, 46-55. 
Allott, K. A., Rice, S., Bartholomeusz, C. F., Klier, C., Schlogelhofer, M., Schafer, M. R. & Amminger, 
G. P. (2015). Facial emotion recognition in unaffected first-degree relatives of individuals with first-
episode schizophrenia. Schizophr Res  161, 322-8. 
Andersen, E. H., Campbell, A. M., Schipul, S. E., Bellion, C. M., Donkers, F. C., Evans, A. M. & Belger, 
A. (2016). Electrophysiological Correlates of Aberrant Motivated Attention and Salience Processing 
in Unaffected Relatives of Schizophrenia Patients. Clin EEG Neurosci  47, 11-23. 
Andric, S., Maric, N. P., Mihaljevic, M., Mirjanic, T. & van Os, J. (2016). Familial covariation of facial 
emotion recognition and IQ in schizophrenia. Psychiatry Res  246, 52-57. 
Ay, R., Boke, O., Pazvantoglu, O., Sahin, A. R., Sarisoy, G., Arik, A. C. & Guz, H. (2016). Social 
Cognition in Schizophrenia Patients and Their First-Degree Relatives. Noro Psikiyatr Ars  53, 338-343. 
Bediou, B., Asri, F., Brunelin, J., Krolak-Salmon, P., D'Amato, T., Saoud, M. & Tazi, I. (2007). Facial 
emotion recognition and genetic vulnerability to schizophrenia. Br J Psychiatry  191, 126-30. 
Bolte, S. & Poustka, F. (2003). The recognition of facial emotion in autistic and schizophrenic 
subjects and their first-degree relatives. Psychological Medicine  33, 907-915. 
Bosnjak Kuharic, D., Makaric, P., Kekin, I., Lukacevic Lovrencic, I., Savic, A., Ostojic, D., Silic, A., 
Brecic, P., Bajic, Z. & Rojnic Kuzman, M. (2019). Differences in Facial Emotional Recognition 
Between Patients With the First-Episode Psychosis, Multi-episode Schizophrenia, and Healthy 
Controls. J Int Neuropsychol Soc  25, 165-173. 
Calkins, M. E., Tepper, P., Gur, R. C., Ragland, J. D., Klei, L., Wiener, H. W., Richard, J., Savage, R. 
M., Allen, T. B., O'Jile, J., Devlin, B., Kwentus, J., Aliyu, M. H., Bradford, L. D., Edwards, N., Lyons, P. 
D., Nimgaonkar, V. L., Santos, A. B., Go, R. C. & Gur, R. E. (2010). Project among African-Americans 
to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of 
neurocognitive functioning in families of schizophrenia patients. Am J Psychiatry  167, 459-72. 
Cardno, A. G., Marshall, E. J., Coid, B., Macdonald, A. M., Ribchester, T. R., Davies, N. J., Venturi, P., 
Jones, L. A., Lewis, S. W., Sham, P. C., Gottesman, II, Farmer, A. E., McGuffin, P., Reveley, A. M. & 
Murray, R. M. (1999). Heritability estimates for psychotic disorders: the Maudsley twin psychosis 
series. Arch Gen Psychiatry  56, 162-8. 
Cella, M., Hamid, S., Butt, K. & Wykes, T. (2015). Cognition and Social Cognition in non-psychotic 
siblings of patients with schizophrenia. Cogn Neuropsychiatry  20, 232-42. 
Coleman, J. R. I., Lester, K. J., Keers, R., Munafo, M. R., Breen, G. & Eley, T. C. (2017). Genome-wide 
association study of facial emotion recognition in children and association with polygenic risk for 
mental health disorders. Am J Med Genet B Neuropsychiatr Genet  174, 701-711. 
da Silva Ferreira, G. C., Crippa, J. A. & de Lima Osorio, F. (2014). Facial emotion processing and 
recognition among maltreated children: a systematic literature review. Front Psychol  5, 1460. 
Daros, A. R., Ruocco, A. C., Reilly, J. L., Harris, M. S. & Sweeney, J. A. (2014). Facial emotion 
recognition in first-episode schizophrenia and bipolar disorder with psychosis. Schizophr Res  153, 
32-7. 
Davalos, D. B., Compagnon, N., Heinlein, S. & Ross, R. G. (2004). Neuropsychological deficits in 
children associated with increased familial risk for schizophrenia. Schizophrenia Research  67, 123-
130. 
Davies, N. M., Holmes, M. V. & Davey Smith, G. (2018). Reading Mendelian randomisation studies: 
a guide, glossary, and checklist for clinicians. BMJ  362, k601. 
de Achaval, D., Costanzo, E. Y., Villarreal, M., Jauregui, I. O., Chiodi, A., Castro, M. N., Fahrer, R. D., 
Leiguarda, R. C., Chu, E. M. & Guinjoan, S. M. (2010). Emotion processing and theory of mind in 
schizophrenia patients and their unaffected first-degree relatives. Neuropsychologia  48, 1209-15. 
Dong, D., Wang, Y., Jia, X., Li, Y., Chang, X., Vandekerckhove, M., Luo, C. & Yao, D. (2017). 
Abnormal brain activation during threatening face processing in schizophrenia: A meta-analysis of 
functional neuroimaging studies. Schizophr Res  197, 200-208. 
Erol, A., Mete, L., Sonmez, I. & Unal, E. K. (2010). Facial emotion recognition in patients with 
schizophrenia and their siblings. Nord J Psychiatry  64, 63-7. 
Fletcher, P. C. & Frith, C. (2009). Perceiving is believing: a Bayesian approach to explaining the 
positive symptoms of schizophrenia. Nature  10, 48-58. 
Germine, L., Robinson, E. B., Smoller, J. W., Calkins, M. E., Moore, T. M., Hakonarson, H., Daly, M. 
J., Lee, P. H., Holmes, A. J., Buckner, R. L., Gur, R. C. & Gur, R. E. (2016). Association between 
polygenic risk for schizophrenia, neurocognition and social cognition across development. Transl 
Psychiatry  6, e924. 
Glahn, D. C., Williams, J. T., McKay, D. R., Knowles, E. E., Sprooten, E., Mathias, S. R., Curran, J. E., 
Kent, J. W., Jr., Carless, M. A., Goring, H. H., Dyer, T. D., Woolsey, M. D., Winkler, A. M., Olvera, R. 
L., Kochunov, P., Fox, P. T., Duggirala, R., Almasy, L. & Blangero, J. (2015). Discovering 
schizophrenia endophenotypes in randomly ascertained pedigrees. Biol Psychiatry  77, 75-83. 
Goghari, V. M., Macdonald, A. W., 3rd & Sponheim, S. R. (2011). Temporal lobe structures and 
facial emotion recognition in schizophrenia patients and nonpsychotic relatives. Schizophr Bull  37, 
1281-94. 
Goghari, V. M., Sanford, N., Spilka, M. J. & Woodward, T. S. (2017). Task-Related Functional 
Connectivity Analysis of Emotion Discrimination in a Family Study of Schizophrenia. Schizophr Bull 
43, 1348-1362. 
Goldschmidt, M. G., Villarreal, M. F., de Achaval, D., Drucaroff, L. J., Costanzo, E. Y., Castro, M. N., 
Pahissa, J., Camprodon, J., Nemeroff, C. & Guinjoan, S. M. (2014). Cluster B personality symptoms 
in persons at genetic risk for schizophrenia are associated with social competence and activation of 
the right temporo-parietal junction during emotion processing. Psychiatry Res  221, 30-6. 
Green, M. F., Bearden, C. E., Cannon, T. D., Fiske, A. P., Hellemann, G. S., Horan, W. P., Kee, K., 
Kern, R. S., Lee, J., Sergi, M. J., Subotnik, K. L., Sugar, C. A., Ventura, J., Yee, C. M. & Nuechterlein, 
K. H. (2012). Social cognition in schizophrenia, Part 1: performance across phase of illness. Schizophr 
Bull 38, 854-64. 
Higgins, J. & Green, S. (2008). Cochrane handbook for systematic reviews of interventions.  (ed. T. C. 
Collaboration). Wiley-Blackwell: UK. 
Horton, L. E., Bridgwater, M. A. & Haas, G. L. (2017). Facial emotion recognition and social skills in 
child and adolescent offspring of parents with schizophrenia. Cogn Neuropsychiatry 22, 175-185. 
Huepe, D., Riveros, R., Manes, F., Couto, B., Hurtado, E., Cetkovich, M., Escobar, M., Vergara, V., 
Parrao, T. & Ibanez, A. (2012). The relationship of clinical, cognitive and social measures in 
schizophrenia: a preliminary finding combining measures in probands and relatives. Behav Neurol 
25, 137-50. 
Ibanez, A., Riveros, R., Hurtado, E., Gleichgerrcht, E., Urquina, H., Herrera, E., Amoruso, L., Reyes, 
M. M. & Manes, F. (2012). The face and its emotion: right N170 deficits in structural processing and 
early emotional discrimination in schizophrenic patients and relatives. Psychiatry Res  195, 18-26. 
Jani, M. & Kasparek, T. (2018). Facial emotion recognition and theory of mind in schizophrenia: A 
meta-analysis of neuroimaging studies. World J Biol Psychiatry  19, S86-S96. 
Kee, K. (2004). Do the siblings of schizophrenia patients demonstrate emotion perception deficits? 
Schizophrenia Research  67, 87-94. 
Knapp, M., Mangalore, R. & Simon, J. (2004). The global costs of schizophrenia. Schizophr Bull  30, 
279-93. 
Kohler, C. G., Richard, J. A., Brensinger, C. M., Borgmann-Winter, K. E., Conroy, C. G., Moberg, P. J., 
Gur, R. C., Gur, R. E. & Calkins, M. E. (2014). Facial emotion perception differs in young persons at 
genetic and clinical high-risk for psychosis. Psychiatry Res  216, 206-12. 
Kohler, C. G., Walker, J. B., Martin, E. A., Healey, K. M. & Moberg, P. J. (2010). Facial emotion 
perception in schizophrenia: a meta-analytic review. Schizophr Bull  36, 1009-19. 
Lavoie, M. A., Plana, I., Bedard Lacroix, J., Godmaire-Duhaime, F., Jackson, P. L. & Achim, A. M. 
(2013). Social cognition in first-degree relatives of people with schizophrenia: a meta-analysis. 
Psychiatry Res  209, 129-35. 
Lavoie, M. A., Plana, I., Jackson, P. L., Godmaire-Duhaime, F., Bedard Lacroix, J. & Achim, A. M. 
(2014). Performance in multiple domains of social cognition in parents of patients with 
schizophrenia. Psychiatry Res  220, 118-24. 
Leppanen, J. M., Niehaus, D. J., Koen, L., Du Toit, E., Schoeman, R. & Emsley, R. (2008). Deficits in 
facial emotion recognition in unaffected siblings of Xhosa schizophrenia patients: evidence for a 
neurocognitive endophenotype. Schizophr Res  99, 270-3. 
Li, H., Chan, R. C., Zhao, Q., Hong, X. & Gong, Q. Y. (2010). Facial emotion perception in Chinese 
patients with schizophrenia and non-psychotic first-degree relatives. Prog Neuropsychopharmacol 
Biol Psychiatry  34, 393-400. 
Li, H. J., Chan, R. C., Gong, Q. Y., Liu, Y., Liu, S. M., Shum, D. & Ma, Z. L. (2012). Facial emotion 
processing in patients with schizophrenia and their non-psychotic siblings: a functional magnetic 
resonance imaging study. Schizophr Res  134, 143-50. 
mandal, m. (1998). Facial expressions of emotions and schizophrenia: a review. Schizophr Bull  24, 
399-412. 
McCown, W., Johnson, J., Austin, S. & Shefsky, M. (1989). Deficits in ability to decode facial 
emotions in families of schizophrenics. Psychotherapy in private practice 6. 
Mendoza, R., Cabral-Calderin, Y., Dominguez, M., Garcia, A., Borrego, M., Caballero, A., Guerra, S. 
& Reyes, M. M. (2011). Impairment of emotional expression recognition in schizophrenia: a Cuban 
familial association study. Psychiatry Res  185, 44-8. 
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. (2009). Preferred reporting items for 
systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6, e1000097. 
Patel, K. R., Cherian, J., Gohil, K. & Atkinson, D. (2014). Schizophrenia: overview and treatment 
options. P T 39, 638-45. 
Rodriguez Sosa, J. T., Gil Santiago, H., Trujillo Cubas, A., Winter Navarro, M., Leon Perez, P., Guerra 
Cazorla, L. M. & Martin Jimenez, J. M. (2013). Social cognition in patients with schizophrenia, their 
unaffected first-degree relatives and healthy controls. Comparison between groups and analysis of 
associated clinical and sociodemographic variables. Rev Psiquiatr Salud Ment  6, 160-7. 
Ruocco, A. C., Reilly, J. L., Rubin, L. H., Daros, A. R., Gershon, E. S.,Tamminga, C. A., Pearlson, G. D., 
Hill, S. K., Keshavan, M. S., Gur, R. C., Sweeney, J. A. (2014). Emotion Rocognition Deficits in 
Schizophrenia-Spectrum Disorders and Psychotic Bipolar Disorder: Findings from the Bipolar-
Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study. Schizophrenia Research 158, 
105-112.  
Savla, G. N., Vella, L., Armstrong, C. C., Penn, D. L. & Twamley, E. W. (2013). Deficits in domains of 
social cognition in schizophrenia: a meta-analysis of the empirical evidence. Schizophr Bull  39, 979-
92. 
Schizophrenia Working Group of the Psychiatric Genomics, C. (2014). Biological insights from 108 
schizophrenia-associated genetic loci. Nature  511, 421-7. 
Spilka, M. J. & Goghari, V. M. (2017). Similar patterns of brain activation abnormalities during 
emotional and non-emotional judgments of faces in a schizophrenia family study. Neuropsychologia 
96, 164-174. 
Toomey, R., Seidman, L. J., Lyons, M. J., Faraone, S. V. & Tsuang, M. T. (1999). Poor perception of 
nonverbal social-emotional cues in relatives of schizophrenic patients. Schizophr Res  40, 121-30. 
Wolf, D. H., Satterthwaite, T. D., Loughead, J., Pinkham, A., Overton, E., Elliott, M. A., Dent, G. W., 
Smith, M. A., Gur, R. C. & Gur, R. E. (2011). Amygdala abnormalities in first-degree relatives of 
individuals with schizophrenia unmasked by benzodiazepine challenge. Psychopharmacology (Berl) 
218, 503-12. 
Yang, C., Zhang, T., Li, Z., Heeramun-Aubeeluck, A., Liu, N., Huang, N., Zhang, J., He, L., Li, H., Tang, 
Y., Chen, F., Liu, F., Wang, J. & Lu, Z. (2015). The relationship between facial emotion recognition 
and executive functions in first-episode patients with schizophrenia and their siblings. BMC 
Psychiatry  15, 241. 
 
 
Table 1: Summary of included studies 
      high risk control group   High risk group Control group  
Study Country Size N mean age % male N mean age % male Measue Mean SD Mean SD Confounders adjusted 
Albacete 2019 Spain 74 37 48.8 43.2 37 41.07 48.6 FEIT 101.3 17.86 110.7 11.37 None 
Alfimova 2009 Russia 154 55 45 50.9 99 32 33.3 FEIT 5.25 5.46 5.8 1.2 Sex, age, education 
Allott 2015  Austria 57 27 32.48 37 30 15.64 50 
FEIT 
Results as separate emotions - see supp. 
Age, IQ, symptoms 
Andersen 2016  USA 75 28 30.7 17.9 47 26.8 53.2 FEIT 13 2.4 13 2.9 Age, sex 
Andric 2016 
Serbia 106 
55 28.56 41.8 51 29.8 45.1 
FEIT 
76.94 8.41 78.1 9.6 
Age, gender, IQ, general 
facial recognition 
Ay 2016 Turkey 60 30 42.4 30 30 33.13 60 FEIT 12.56 1.99 14.2 1.88 None 
Bediou 2007 Morocco 56 30 31.2 100 26 24.3 100 FEIT 0.565 0.10 0.6 0.10 Age, education 
Bolte 2003 Germany 66 46 41.30 49.99 22 29.7 50 FEIT 38.94 4.39 42.9 1.3 Age, IQ 
Calkins 2010  USA 1262 928 45.6 32.21 334 42.4 42.8 FEIT Results given as cohen d = -0.39 p<0.0001 Sex, age 
Cella 2015  
UK 
42 
21 33.7 52.4 21 27.3 28.6 
FEIT 
13.52 1.8 14.5 1.2 
Age, gender, education, IQ, 
cognitive function 
Coleman 2017  
UK 4097 
   
4097 8 49.6 
FEIT 
Results as separate emotions - see supp. 
White western European 
ancestry 
Davalos 2004  USA 102 51 10.22 64.7 51 10.45 64.7 FEIT 18.85 8.38 17.8 2.7 None 
deAchaval 2010  
Argentina 
40 
20 50.1 45 20 44.2 45 
FEIT 
16.6 2.8 18.1 1.5 
Age, cognitive performance, 
education 
Erol 2010  
Turkey 
116 
58 34.4 58.6 58 33.6 60.3 
FEIT 
12.2 2.5 13.7 1.6 
Age, education, illness 
duration and BPRS 
Germine 2016  USA 4303 
   
4303 13.8 50 FEIT Numerical data not presented white non-Hispanic ancestry 
Goghari 2011  USA 59 23 49.8 35 36 42.1 66 FEIT Results as separate emotions - see supp. Age 
Goghari 2017  
Canada 
 
46 25 41.2 40 21 43.4 52.4 
 
FEIT Results as separate emotions - see supp. 
 
None 
Goldschmidt 2014 Argentina 
28 
14 30.4 57 14 28.4 57 
FEIT 
97 5 99 2 
None 





14 45.79 40 18 40.5 61.1 
FEIT 






13 47.31 46.15 13 39.46 69.23 FEVT 76 6.93 81.5 6.36 
None 
Kee 2004 USA 100 51 38.64 43 49 36.38 49 FEIT 13.41 2.52 14.1 2.39 None 




31 56.1 29 38 54.55 29 
FEIT 
11.42 1.43 11.84 1.42 






23 36 35 22 40.9 50 
FEIT 
Results as separate emotions - see supp. 
None 
Li 2010 China 90 23 30 52 67 26 67 FEIT 57.93 21.84 64.3 11.32 None 
Li 2012 China 24 12 31.25 33.3 12 29.25 50 FEIT Results as separate emotions - see supp. None 
McCown 1989 USA 100 50 45.31 50 50 46.45 50 FEIT 70.04 7.97 73.7 9.34 None 
Mendoza 2011 Cuba 219 110 42.01* 59.1 109 33.6* 36.7 FEIT Results as separate emotions - see supp. Age, gender, education 
Ruocco 2014 USA 712 332 42.65 30 380 37.71 47 ER-40 -0.34 0.07 0 1 Age, race and sex 
Spilka 2017 Canada 54 27 41.19 37 27 40.7 48.1 FEDT 90.65 4.72 89.73 4.03 None 
Toomey 1999 USA 40 21 46.2 24 19 43.4 21 FEIT 55.3 7.1 57 3.8 None 





56 26 23.9 46.2 30 24.6 50 
 
FEIT Results separated by emotion and intensity 
None 
Notes on table 1: Highlighted studies were included in meta-analysis by Lavoie et al (2013). * median values. FEIT facial emotion identification test. FEDT 







Prisma Flow Diagram 
(see file figure 1) 
 
 
Figure 2  
Forrest Plot for Meta-analysis of standardised mean difference for facial emotion recognition test 
(see file figure 2) 
Footnote:  
Markers signify which studies are additional inclusions to the studies reviewed in the paper by Lavoie et al 2013. 
Positive results demonstrate higher standardised mean difference between scores on facial emotion recognition tests achieved by people at 





Funnel plot for meta-analysis of facial emotion recognition 
(See file figure 3) 
 
Figure 4 
Forrest Plot for Meta-analysis of standardised mean difference for facial emotion recognition test for facial expressions with negative valence.  
(see file figure 4) 
Footnote:  
Positive results demonstrate higher standardised mean difference between scores on facial emotion recognition tests achieved by people at 
low genetic risk of psychosis compared with those at high genetic risk of psychosis. 
 
Figure 5 
Forrest Plot for Meta-analysis of standardised mean difference for facial emotion recognition test for facial expression with positive valence 
(see file figure 5) 
Footnote:  
Positive results demonstrate higher standardised mean difference between scores on facial emotion recognition tests achieved by people at low genetic 
risk of psychosis compared with those at high genetic risk of psychosis. 
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Reviewers' Comments and author responses 
 
 
Reviewer 1 comments: 
 
 1.      A main concern is what the current findings add above and beyond the meta-analysis conducted by 
Lavoie et al. (2013), other than the addition of some additional articles added to the meta-analysis. The authors 
report that using individual-level data from GWAS studies may improve our ability to assess associations with 
genetic risk in emotion recognition deficits, yet review is only provided for 2 studies, which ultimately do not 
support this position. I believe the study would be more impactful if additional data could be provided. E.g., Meta-
analysis of negative (combining anger, fear, disgust) vs. positively valanced (happy) vs. neutral emotions for 
those studies that report emotion specific deficits. 
 
We appreciate this concern about what this review adds above and beyond the meta-analysis by Lavoie et al 
(2013) other than updating the review through the addition of 17 studies that we have included that were not in 
that review. As suggested, we have now also included meta-analyses of negative (anger, fear, disgust and 
sadness), positive and neutral emotions for those studies which report specific deficits. This was a useful 
addition to our manuscript as it highlights how strong the evidence is for deficits in the recognition of negative 
emotions in those with first-degree relatives of people with schizophrenia. We have expanded our description of 
what our reviews adds to this area of research in the discussion section (first paragraph). 
 
 2.      One study that is omitted from the meta-analysis is that by Ruocco et al, 2014 from the B-SNIP 
consortium. This is a large study (n>250 schizophrenia relatives) using a well-validated emotion recognition task, 
and based on the selection criteria it is not clear why this study is not included. This seems particularly important 
to include, as it is among the larger studies reported in the literature and it was published after the Lavoie et al. 
2013 meta-analysis. Further, data are reported for specific emotions, which would allow for inclusion in the meta-
analysis on the subset of studies that evaluation specificity of deficits. 
 
We are grateful to the reviewer for pointing out this omission. This study was picked up in our search but was 
mistakenly omitted from our review, for which we do apologise. We have now added this study to our review and 
included it in all meta-analyses, and it has proved to be influential in strengthening the findings of our review. 
 
 3.      Through the manuscript (e.g., 2nd sentence of abstract, 1st sentence of 3rd paragraph of introduction, 
etc.) the authors use language specifying a "causal effect" of emotion recognition deficits on schizophrenia, 
which I believe overstates what the studies they review are reasonably measuring, which are really associations. 
I appreciate the authors point that studying unaffected relatives may remove some of the confounds and cause 
vs. effect issues when studying affected individuals, but I think tempering of this language would improve the 
manuscript. 
 
We had not meant to give the impression that the evidence of association between emotion recognition deficits 
and schizophrenia is causal, but only that studies that can minimize other explanations such as reverse 
causation and confounding are required to more robustly understand this relationship. We have therefore 




 4.      Is any statistical correction for multiple meta-analyses provided for the evaluation of deficits in specific 
emotions? 
 
We did look into whether any statistical correction for multiple meta-analyses was required, and decided to follow 
the advice from Cochrane systematic review guidance (see link below), which states that statistical correction for 
meta-analyses is not generally recommended. However, Cochrane do advise that overall conclusions are more 
difficult to draw if there are multiple analyses. We have therefore encouraged cautiousness in interpretation of 






 5.      The authors should report effect sizes for the findings from reviews of the studies using polygenic risk 
scores vs. p values alone. As the authors note in the discussion, the substantial subject sizes of these studies 
increase statistical power, which indicates finding of statistical significance (p=. 032) reflect a very small effect. 
 
We agree that this would be useful, but unfortunately the studies haven not standardised their scores and so 
effect sizes are not interpretable, as outlined by Mistry et al (https://www.ncbi.nlm.nih.gov/pubmed/29129507) 
 
 Reviewer #3:  
 
 The authors mention that a systematic review and meta-analysis conducted in this topic was reported in 2013.  
In this context, the authors have mentioned that 16 additional studies have been included in this present meta-
analysis that was not evaluated in the previous one.  In the figure 2 that has listed these studies, many are found 
to be published 2012 - it will be helpful if the authors could list the 16 additional studies separately 
 
We have now added markers on figure 2 to signify which studies are additional inclusions to the studies 
reviewed in the paper by Lavoie et al 2013. 
 
 The authors may want to explain the additional new findings that are available through this present meta-
analysis. 
 
We have added more detail in our discussion section (first paragraph) on the new findings available through our 
meta-analyses; namely, an update of the evidence through the inclusion of 17 additional studies in our review, 
11 additional studies in our overall facial emotion recognition meta-analysis, and our meta-analyses for separate 
valences and specific emotions.  
 
 The supplementary material document could not be accessed by this reviewer to learn about the details of the 
excluded studies.  For example, fMRI study by van der Velde et al 2015 may be a potential research publication 
for this meta-analysis.  Similar studies that have evaluated emotion processing with concurrent assessment of a 
neurobiological parameter (like fMRI) are important to consider. 
 
Thank you for this suggestion and we are sorry to hear that you were unable to see our supplementary 
documents. The study by Velde et al from 2015 does not meet our inclusion criteria as they recruited people at 
“ultra high-risk” based on CAARMs scoring rather than on genetic (or familial) risk. In reference to the inclusion 
of studies assessing neurobiological parameters, we have included a number of such studies where they met 
our inclusion criteria (for example: Goghari et al 2017, Spilka et al 2017 and Wolf et al 2011), and extracted the 
relevant data for the purpose of this review.  
 
 
 With regards to emotion processing task, it will be helpful to know the summary of different type of experiments 
(for example using static versus dynamic stimuli / similar other parameters) and the potential impact of these 
parameters on the findings. 
 
All included studies used static stimuli, some with a time-limit for how long the stimuli were shown and some with 
no time limits. We examined whether differences in the use of time limits reduced heterogeneity as part of our 




 Reviewer #4: 
 
 1.      The main concern with this manuscript is related to the conclusion that the authors are drawing based on 
the results of this meta-analysis. It is unclear if showing that first-degree relatives with schizophrenia have lower 
emotion recognition is in any way indicative that this endophenotype could not also be partly a consequence of 
schizophrenia. First-degree relatives of schizophrenia have about 10 times more risk of developing the illness 
compared to the general population. More longitudinal research in youth at genetic risk of schizophrenia is 
needed to determine whether lower emotion recognition could increase the risk of developing the illness. 
Furthermore, it is possible that some people with schizophrenia develop more pronounce emotion recognition 
deficits following the first episode of psychosis. These last points should probably be address in the discussion, 
and I would advise to remove the references to causality (or the absence of) in the manuscript. 
 
We believe that reverse causation (schizophrenia leading to emotion recognition deficits) is an unlikely 
explanation for our findings as participants in the majority of studies included in our review had been screened to 
ensure they did not have schizophrenia.  
However, we agree with the reviewer that further longitudinal research is required to determine if emotion 
recognition deficits have a causal effect on schizophrenia onset or relapse. We also appreciate that such 
observational studies will always be limited in their ability to determine causality due to concerns around residual 
confounding. It is probably only through trials of interventions that target such deficits, or causal inference 
methods such as Mendelian randomisation (once genetic instruments for these deficits become available) that 
our ability to determine causal effects of emotion recognition on schizophrenia will be substantially improved. We 
have added these points to the discussion section (Paragraph 5) and re-phrased the sections referring to 
causality (introduction and discussion)  
 
 
 2.      In this meta-analysis, the authors included individuals with first-degree relatives with psychosis. The 
authors noted that only 70% of these individuals had schizophrenia (mentioned in section 2.3). What was the 
diagnosis for the other 30%? How did the authors ensure that these studies fall within the inclusion criteria for 
genetically high-risk for schizophrenia? The differences between schizophrenia related risk and/or non-
schizophrenia risk should be further explained for each individual study included in the analysis. 
 
Thank you for raising this important point. This criterion was actually introduced in relation to a separate 
systematic review we were conducting in parallel that was examining other cognitive biases in first-degree 
relatives, and should not have been applied to this review where our original protocol specified that all 
participants should have had a first-degree relative with schizophrenia. There were 2 studies that included 
participants who had a first degree relative with other, non-schizophrenia psychotic disorders in our original 
submission, and these have now been excluded to ensure that all included studies met our original protocol.  
 
 3.      The current Table 1 on the quality of assessment tool could be moved into supplementary material. In 
replace of Table 1 within the manuscript, the authors could include a Table 1 that is more informative of the 
studies included in the meta-analysis in their manuscript. For example, there could be a Table presenting the 
main characteristics of each study included in the meta-analysis (e.g., n=, diagnosis of first-degree relatives, 
age, sex ratio, IQ, etc.). 
 
We are happy to include a table summarising the included studies main characteristics and therefore we have 
changed table 1, as suggested. However, we are aware it is a very large table and therefore leave it to the 
editorial team to decide where to include this. 
 
 4.      In 2.6, the authors mention that any discrepancies in quality assessment rating were resolved by 
discussion with a third reviewer. How was this conducted, and was the process by which the confounding's were 
assessed? 
 
Discrepancies in quality assessment rating were resolved after discussion with a third reviewer (SZ) at a meeting 
where relevant information from the study was assessed to enable a collaborative agreement on what level of 
criteria the study had met for the discrepancy in question. Our decision on what we deemed to be appropriate 
consideration of confounders was based on discussions between the reviewing team as to which factors we 
believed were most plausible as confounding factors based on current knowledge from the literature.  
 
 
 5.      How were the meta-analysis and narrative synthesis compared? The inclusion of both in the same 
manuscript is a bit confusing. Maybe the authors could only focus on the meta-analysis in their results section 
and discuss the other manuscripts in the discussion? 
 
We believe that these studies should be included in the results section as they were identified in our search 
strategy and as they still contribute to the body of evidence, even if not to the meta-analysis estimate. As we 
discuss, the results from the narrative summaries are consistent with the results from the meta-analyses, adding 
further support to the evidence of association. We have added a sentence to the discussion section to highlight 
this (first paragraph of discussion, last sentence). 
 
 6.      Evidence of some publication bias (3.2) was mentioned. How was this accounted for in the study? There is 
no mention of this process. 
 
We examined publication bias using a funnel plot and egger test, which shows little evidence (p = 0.54) of such 
bias. We have added further details as to how the methods used in our review attempts to address publication 
bias to the first paragraph of our results section.  
 
 
 Minor Concerns: 
 
1. In the second paragraph of the introduction, it is stated that facial emotion recognition deficits in 
schizophrenia are associated with neuro-radiological differences seen on fMRI. What are these 
differences? Please elaborate. 
 
We have elaborated on these differences in the introduction section (second paragraph), as follows: 
 
“Facial emotion recognition deficits in schizophrenia are associated with an extensive pattern of activation 
abnormalities on fMRI, consistent with hypoactive emotion recognition networks (Jani and Kasparek, 2018). 
Compensatory over-activation in the medial prefrontal cortex (MPFC) during threatening faces processing has 
also been demonstrated (Dong et al., 2017).” 
 
 
2. It was a bit unclear whether there was a specific genetic link that was assessed in some studies (i.e., 
specific genome sequence for schizophrenia or heritability). For the two GWAS included, what were the 
common genes for schizophrenia risk? Please elaborate 
 
Both included studies used polygenic risk scores derived using the weighted sum of risk alleles (at multiple p-
thresholds in one study, and at a p-threshold of <0.05 in the other study) for schizophrenia identified from the 
GWAS by the Schizophrenia Working Group of the Psychiatric Genomics, 2014. Hence these scores would 
have been based on thousands of SNPs across the genome. We have added a sentence to the results section 
to clarify this (section.3.4).   
 
 
3. In 2.6, the authors mentioned that two independent viewers assessed the quality of the individual studies, 
but there seems to be three reviewers (DM, AP and DS). Please clarify. 
 
We have clarified the process in section 2.6: (each study assessed by DM and either AP or DS). 
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